News

The 'CoComelon' live show is coming to a city near you. Your kids listen to the CoComelon music playlists on Spotify. Thanks ...
Once-daily oral IL-23 inhibitor icotrokinra (formerly JNJ-2113) – which J&J licensed from Protagonist Therapeutics in 2017 – hit both its main efficacy objectives in the ICONIC-LEAD trial ...